To the Editor: The coronavirus disease (COVID-19) is though primarily a respiratory tract infection, various extra-pulmonary complications have also been reported. We hereby report dilated cardiomyopathy (DCM) in a one-year-old premorbidly healthy boy.
A one-year-old boy presented with low-grade fever for two days, followed by generalized swelling all over body and tachypnea for one week. Past and family history were not contributory. He was admitted in an outside hospital for five days with diagnosis of congestive cardiac failure (CCF). Investigations done there revealed cardiomegaly on chest X-ray (CXR), iron deficiency anemia (Hb 6.3 g/dl, microcytic hypochromic smear, ferritin 3.4 μg/L), deranged liver function tests (total bilirubin 1.55 mg/dl, indirect 1.13 mg/dl, AST 245 U/L, ALT 280 U/L, ALP 278 U/L) and normal CRP (0.7 mg/L). Rest of the investigations were normal. Echo revealed dilated ventricles with global hypokinesia with left ventricular ejection fraction of 12% and normal coronaries. Child was managed symptomatically and referred for specialized care.
At presentation to our hospital he had tachycardia, tachypnea (heart rate 170/min, respiratory rate 36/min) and SaO2 of 97% in room air. He was still in CCF with basal crepitations and hepatomegaly of 4 cm. Investigations in Emergency department (ED) showed cardiomegaly on CXR, Hb 8.7 g/dL, TLC 12,200 with 50% neutrophils, 43% lymphocytes and platelet count of 74,000/mm3. The electrocardiogram (ECG) did not show any abnormality. In view of severe left ventricular dysfunction and CCF, furosemide and dobutamine infusion was started. His rRTPCR for the SAR-CoV-2 ORF 1ab gene done by a commercial kit (BGI Genomics Co. Ltd., China) on nasopharyngeal swab was positive. He was admitted in isolation ward while inotropes and diuretics were continued. However, his CCF persisted and inotropes were hiked. He suffered a sudden cardiac arrest 33 h after admission from which he could not be revived.
Viral infection is a known secondary cause of DCM [1]. CCF has been reported in 23% of COVID-19 patients [2]. Arentz et al. reported cardiomyopathy in 33% of critically sick COVID-19 patients [3]. Viral myocarditis may also present acutely with CCF and ventricular dilation but has a milder course while fulminant myocarditis has normal cardiac chamber sizes [4]. Our patient had normal ECG and inflammatory markers. He had recent onset cardiomyopathy, as he was premorbidly normal, did not have pneumonia, metabolic abnormality, or fluid overload, ruling out secondary myocardial dysfunction or stress cardiomyopathy. DCM was possibly due to coronavirus infection though the etiological role of the virus could not be proved.
Acknowledgments
Director General, Indian Council of Medical Research, for providing funding for support of diagnostics.
Compliance with Ethical Standards
Conflict of Interest
None.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet. 2010;375:752–762. doi: 10.1016/S0140-6736(09)62023-7. [DOI] [PubMed] [Google Scholar]
- 2.Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA. 2020;323:1612–1614. doi: 10.1001/jama.2020.4326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, Klingel K, Kandolf R, Sechtem U, Cooper LT, Böhm M. Update on myocarditis. J Am Coll Cardiol. 2012;59:779–792. doi: 10.1016/j.jacc.2011.09.074. [DOI] [PubMed] [Google Scholar]